Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescription

医学 心力衰竭 射血分数 药物治疗 药方 内科学 持久性(不连续性) 心脏病学 药店 倾向得分匹配 药物依从性 重症监护医学 物理疗法 螺内酯 联合疗法 心脏病
作者
Felix Lindberg,Alicia Uijl,Lina Benson,Valeria Valente,Andrew J. S. Coats,M. Bohm,Marco Metra,Stefano Masi,Lars H Lund,G.M.C. Rosano,Gianluigi Savarese
出处
期刊:European Heart Journal [Oxford University Press]
被引量:1
标识
DOI:10.1093/eurheartj/ehag199
摘要

BACKGROUND AND AIMS: Real-world uptake of heart failure with reduced ejection fraction (HFrEF) treatments relies on physician prescriptions but also on patient adherence. This study assessed implementation of, patient adherence and persistence with quadruple HFrEF therapy in the contemporary setting, and associations with morbidity/mortality. METHODS: Patients with HFrEF enrolled in the Swedish Heart Failure Registry between January 2016 and December 2023 were included. Using pharmacy refills, patients with ≥80% proportion of days covered were categorized as adherent and with dispensations at 12 ± 2 months post-index as persistent. RESULTS: In 35 215 patients with HFrEF [median age 74 (interquartile range 64-80) years; 28% female], use of all four HFrEF foundational therapies increased between 2016 and 2023: in 2023, 93% used beta-blockers (BB), 95% renin-angiotensin-system inhibitors (RASi)/angiotensin receptor-neprilysin inhibitors (ARNi), 73% mineralocorticoid receptor antagonists (MRA), 83% sodium-glucose co-transporter 2 inhibitors (SGLT2i), and 60% quadruple therapy. The proportion of patients who were adherent and persistent, respectively, to BB was 95% and 90%, RASi/ARNi 95% and 89%, MRA 90% and 77%, SGLT2i 94% and 86%, and quadruple therapy 85% and 67%. Good adherence and persistence for BB, RASi/ARNi, and MRA and good adherence for SGLT2i were independently associated with lower heart failure hospitalization/cardiovascular death. CONCLUSIONS: By 2023, use of quadruple therapy reached ∼60%, being mostly limited by lower adoption of MRA (∼73%). Patient adherence to foundational therapies was high and appeared associated with better prognosis. These data suggest that improvements in the uptake of and adherence to quadruple HFrEF pharmacotherapy are achievable in real-word heart failure care, although suboptimal dosing and frequent discontinuations remain important areas of further implementation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
jia发布了新的文献求助10
1秒前
liyuheng20完成签到,获得积分10
1秒前
1秒前
感动的丝发布了新的文献求助10
1秒前
小刺儿发布了新的文献求助10
2秒前
SciGPT的应助被Betty采纳,获得10
3秒前
yaaaaajie完成签到,获得积分10
3秒前
orixero的应助被Felicity采纳,获得10
3秒前
lld发布了新的文献求助10
4秒前
liyuheng20发布了新的文献求助10
5秒前
在水一方的应助被朴素绮菱采纳,获得10
5秒前
李孟林发布了新的文献求助10
6秒前
6秒前
6秒前
缄默发布了新的文献求助10
7秒前
我很好哈哈哈呵呵嗯嗯完成签到,获得积分10
8秒前
wenmindeng的应助被糊涂涂采纳,获得10
8秒前
Enya发布了新的文献求助10
8秒前
wyf发布了新的文献求助10
8秒前
orixero的应助被感动的丝采纳,获得10
10秒前
10秒前
ysy完成签到 ,获得积分10
10秒前
lll发布了新的文献求助10
11秒前
李孟林完成签到,获得积分10
12秒前
orixero的应助被不期而遇采纳,获得10
13秒前
小猪发布了新的文献求助10
13秒前
15秒前
zzzllove发布了新的文献求助10
15秒前
16秒前
16秒前
17秒前
18秒前
熠熠完成签到,获得积分10
18秒前
20秒前
20秒前
qingqiu发布了新的文献求助10
20秒前
真王一博发布了新的文献求助30
20秒前
YangZai发布了新的文献求助10
20秒前
xux发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
Organizational Behavior 510
Management and the Arts 510
Convergent and bidirectional strategies towards the total synthesis of hemibrevetoxin B 300
Geschichtliche Grundbegriffe (GGB), Band 5: Pro–Soz 300
Die Religion in Geschichte und Gegenwart (RGG), 4. Auflage, Band 7: R–S 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7795790
求助须知:如何正确求助?哪些是违规求助? 9331656
关于积分的说明 20445117
捐赠科研通 7385998
什么是DOI,文献DOI怎么找? 3324833
关于科研通互助平台的介绍 2472255
邀请新用户注册赠送积分活动 2341950